Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$742,852
+$22,483 QoQ
Shares Held
4,740
+0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#728
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sigma Planning Corp holds $73,658,587 across 13 Drug Manufacturers - General names. NVS ranks #11 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,696 | $17,626,824 | |
| 2 | JNJ |
Johnson & Johnson
|
62,029 | $15,753,505 | |
| 3 | ABBV |
AbbVie Inc.
|
55,986 | $14,088,317 | |
| 4 | MRK |
Merck & Co., Inc.
|
45,541 | $5,852,018 | |
| 5 | AMGN |
Amgen Inc
|
14,019 | $5,076,560 | |
| 6 | PFE |
Pfizer Inc
|
210,735 | $5,074,498 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
76,251 | $4,393,582 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
13,992 | $1,767,749 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $742,852 | 4,740 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $720,369 | 4,716 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $702,723 | 5,097 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,432,184 | 11,168 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $624,048 | 5,157 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $543,465 | 4,875 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $410,453 | 4,218 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $601,554 | 5,230 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $587,446 | 5,518 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $571,480 | 5,908 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $238,491 | 2,362 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $724,835 | 7,116 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $720,194 | 7,137 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $710,792 | 7,726 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $584,508 | 6,443 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $843,939 | 11,103 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $935,408 | 11,066 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $521,235 | 5,940 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $669,145 | 7,650 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $963,531 | 11,782 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,052,179 | 11,532 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,014,049 | 11,863 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,041,374 | 11,028 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,006,996 | 11,580 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $1,026,594 | 11,754 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $571,955 | 6,937 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||